Global Stem Cells Group

Global Stem Cells Group Global Stem Cells Group is a collection of leading edge companies in the explosively growing stem ce

Especialidad en implantes de celulas madres desde tejido graso y medula osea de origen autologo

The Global Stem Cells Group owns a proprietary protocol to harvest adult stem cells from adipose tissue as well as bone marrow. This proprietary, research-backed technique, coupled with the company’s synergistic strategy that includes platforms for research, education, and treatment, provides a measurable market advantage as well as assurance that our patients and physicians will enjoy the most favorable possible outcomes from stem cell treatments. No other company offers the breadth of education, research and treatment options that The Global Stem Cells Group can offer. The Global Stem Cells Group’s companies offer everything necessary for physicians to begin utilizing stem cell therapy treatments with their patients. In addition, the company offers consumer and patient education that will continue to fuel demand for the treatments. Research indicates that stem cell therapies are poised for explosive growth worldwide, and new products for treatments of diabetes, cardiovascular disease and nerve repair are on the horizon. Our unique approach incorporating research, education and treatment positions us to become the recognized leader in autologous stem cell treatments.

12/22/2025
12/22/2025

In 2025, ISSCA brought regenerative medicine education beyond borders.
Across continents and clinical realities, physicians came together to learn, connect, and get grow

From international conferences and certifications to clinic inaugurations, MedConnect gatherings, and global summits, ISSCA strengthened a worldwide medical community committed to the future of regenerative medicine.

This year was about shared knowledge, clinical excellence, and global collaboration.
A network of physicians united by education, science, and purpose.

This is ISSCA.
A global platform for regenerative medicine education.

🌍 Global Medical Education
🎓 International Certification
🤝 A Worldwide Physician Community

12/19/2025

Sketchy peptides 👀

If the vial says “GLP” and the water says “BAC”… we need to talk.

Peptides without proper purification and testing can raise unwanted levels in the body.

And that’s a risk no patient should take.

👉 Learn how to use peptides properly in our online course.

Comment “PEPTIDES” and we’ll send you all the information.

12/18/2025
12/17/2025

Peptide Online Certification 🔥🔥

Address

Datran Center 9100 S Dadeland Boulevard, Suite 1500
Miami, FL
33156

Opening Hours

Monday 9am - 6pm
Tuesday 9am - 6pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm

Telephone

+13055605337

Website

Alerts

Be the first to know and let us send you an email when Global Stem Cells Group posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

The Global Stem Cells Group owns a proprietary protocol to harvest adult stem cells from adipose tissue as well as bone marrow. This proprietary, research-backed technique, coupled with the company’s synergistic strategy that includes platforms for research, education, and treatment, provides a measurable market advantage as well as assurance that our patients and physicians will enjoy the most favorable possible outcomes from stem cell treatments. No other company offers the breadth of education, research and treatment options that The Global Stem Cells Group can offer. The Global Stem Cells Group’s companies offer everything necessary for physicians to begin utilizing stem cell therapy treatments with their patients. In addition, the company offers consumer and patient education that will continue to fuel demand for the treatments. Research indicates that stem cell therapies are poised for explosive growth worldwide, and new products for treatments of diabetes, cardiovascular disease and nerve repair are on the horizon. Our unique approach incorporating research, education and treatment positions us to become the recognized leader in autologous stem cell treatments.